Home Stipple Bio

Stipple Bio

In operation
Series A
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

Stipple Bio is a biotechnology company aimed at achieving breakthroughs in cell analysis and target discovery. The company provides antigen-level resolution technology for single-cell analysis, capable of identifying new therapeutic targets and developing precision therapies, enabling users to offer treatment solutions for various solid tumors and hematological malignancies.
Stipple Bio, Inc.
Cambridge,Massachusetts,United States of America
less than 15 people
January 01, 2021
info@stipplebio

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs ADC (Antibody-Drug Conjugate)